Compare Aurora Cannabis Inc (ACB) vs GameStop Corp. (GME) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

GME trades at $22.2, down 2.72% on the day, with a bullish technical signal from moving averages and a neutral stance from oscillators. The company reported a net income margin of 20.45% for 2025, with recent quarterly earnings beating expectations. Key developments include shareholder approval for increased share issuance and CEO Ryan Cohen's focus on a potential eBay acquisition, alongside a withdrawn $35 billion pay package to prioritize the takeover bid.

The outlook is mixed, with strong profitability and bullish technicals offset by a cautious analyst consensus and strategic risks from the eBay pursuit. Investment opportunities lie in continued earnings growth and strategic initiatives, while risks include integration challenges, competitive pressures in physical media, and reliance on CEO-driven strategy.